PASSIVE IMMUNONEUTRALISATION OF HUMAN IMMUNODEFICIENCY VIRUS IN PATIENTS WITH ADVANCED AIDS
- 1 September 1988
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 332 (8612) , 647-652
- https://doi.org/10.1016/s0140-6736(88)90468-0
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Correlation of serum HIV antigen and antibody with clinical status in HIV‐I infected patientsJournal of Medical Virology, 1987
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.BMJ, 1986
- T-cytotoxic/suppressor cell phenotypes in a group of asymptomatic homosexual men with and without exposure toClinical Immunology and Immunopathology, 1986
- Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 MoleculeScience, 1986
- Major Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-IIIScience, 1985
- Antibodies to HTLV-III in Swiss Patients with AIDS and Pre-AIDS and in Groups at Risk for AIDSNew England Journal of Medicine, 1985
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- Lymphadenopathy-Associated Viral Antibody in AIDSNew England Journal of Medicine, 1984